Portal de Periódicos da CAPES

Congenital varicella syndrome: A systematic review

2016; Informa; Volume: 36; Issue: 5 Linguagem: Inglês

10.3109/01443615.2015.1127905

1364-6893

Ki Hoon Ahn, Yun-Jung Park, Soon–Cheol Hong, Eun Hee Lee, Ji Sung Lee, Min‐Jeong Oh, Hai‐Joong Kim,

Parvovirus B19 Infection Studies

Varicella-zoster virus (VZV) is a teratogen that can cross the placenta and cause the congenital varicella syndrome (CVS), which is characterised by multi-system anomalies. There have been 130 reported cases of CVS from 1947 to 2013. The estimated incidence of CVS was 0.59% and 0.84% for women infected with VZV during the entire pregnancy and for those infected the first 20 weeks of pregnancy, respectively. Nine cases were reported at 21–27 weeks of gestation and one case was identified at 36 weeks. Herpes zoster caused CVS in two cases. Regarding treatment, varicella zoster immunoglobulin treatment, irrespective of gestational age, should be considered in addition to antiviral drugs for women who have been exposed to or infected with virus.